News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Clinical - Drug Product News (World)
Oasmia Announces Commercial Launch Of Paclical In Russia And CIS Countries 10/5/2015
Roche Canada Release: Biologic Treatment Option Now Available To Canadian Women Living With Advanced Ovarian Cancer 10/5/2015
Lupin (LUPN.BO) Hikes Diabetes Drug Price by 200% in the U.S. 9/25/2015
Novartis AG (NVS) Launches New Portfolio Of Affordable Medicines for Poor Countries 9/24/2015
Complaints for Bayer AG (BAYZF)'s Sterility Device Spike Nearly 1,400% in Three Years 9/22/2015
Turing Pharma’s Toxoplasmosis Treatment Spikes 5,000% Overnight 9/22/2015
ibidi Product News: Ibidi µ-Slide 8 Well Grid-500: Track Down Your Cells In A µ-Slide 8 Well 9/21/2015
Information Update - Health Canada Proposes Revised Labelling Standard For Non-Prescription Acetaminophen Products 9/16/2015
Mylan (MYL) Launches Generic Unasyn For Injection 9/14/2015
Allergan (AGN) Expands Access To IUDs For Millions Of Underserved Women In The US By Announcing Agreement With Apexus For Nationwide Distribution Of LILETTA (Levonorgestrel-Releasing Intrauterine System) 52 Mg 9/10/2015
Vernalis Therapeutics Launches Long-Acting Codeine-Based Cough Suppressant Ahead Of U.S. Cough Cold Season 9/8/2015
Roche (RHHBY) Chief Blasts U.K. Decision to Not Cover Costs of Some Cancer Treatments 9/8/2015
Novartis AG (NVS) Takes on Amgen (AMGN) With Launch of the First U.S. Biosimilar 9/4/2015
Allergan (AGN) Announces FDA Approval Of Updated Label For TEFLARO (ceftaroline fosamil) 9/2/2015
Laccure's Antibiotic-Free OTC Product For Bacterial Vaginosis Ready For Commercialisation 9/1/2015
Teva (TEVA) Announces U.S. Availability Of ZECUITY (Sumatriptan Iontophoretic Transdermal System), First And Only Transdermal Patch System For The Acute Treatment Of Migraine 9/1/2015
Endo Pharmaceuticals (ENDP) Announces XIAFLEX For Dupuytren's Contracture Formal Pricing In Japan; Commercial Launch Set For September 16, 2015 8/31/2015
BioSpecifics Technologies Corporation (BSTC) Announces Formal Pricing Of XIAFLEX For The Treatment Of Dupuytren's Contracture In Japan 8/31/2015
Generex Biotechnology Corporation (GNBT) Announces Issuance of Buccal Insulin White Paper 8/27/2015
ReproCELLl: Joint Press Announcement With Institute For Frontier Medical Sciences, Kyoto University 8/26/2015
Hospira Release: TGA Approves First mAb Biosimilar 8/20/2015
Endo International (ENDP) Announces U.S. District Court Ruling Upholding OPANA ER Intellectual Property 8/17/2015
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of PRAMIPEXOLE Dihydrochloride Extended-Release Tablets 8/12/2015
Fight Intensifying Over Which Patients Will Get Regeneron (REGN), Sanofi (SNY)'s $15,000 a Year Cholesterol Drug 8/12/2015
Innova Biosciences Introduces Range Of Conjugated Antibodies 8/10/2015
Watchdog Accuses Pfizer (PFE) of Overcharging By Millions for Epilepsy Drug 8/6/2015
Hetero Announces The Launch Of Biosimilar Rituximab (MABALL) In India 8/5/2015
Omeros Corporation (OMER) Release: Omidria Approved For Commercialization Throughout The European Union And Additional Countries 8/3/2015
Boehringer Ingelheim Welcomes The Inclusion Of OFEV (Nintedanib*) In The Updated International Treatment Guidelines For Idiopathic Pulmonary Fibrosis (IPF) 7/15/2015
Daiichi Sankyo Release: New Therapy To Help Heart Rhythm Patients Means Doctors Are "Spoilt For Choice" 7/10/2015
SANTEN Launches TAPTIQOM Preservative-Free Fixed Combination Eye Drops In The UK 7/10/2015
EXCLUSIVE: Ironwood (IRWD), AstraZeneca PLC (AZN) IBS-C Drug Will File in China Next Year, CEO Tells BioSpace (DHX) 7/9/2015
Teva (TEVA) First To Receive Approval And Launch Generic Axert Tablets In The United States 7/9/2015
Consumer Watchdog Asks FDA to Revoke Approval of Sanofi (SAN.PA)'s Seprafilm 7/8/2015
Novo Nordisk A/S (NVO) Pulls Tresiba Off Shelves in Germany 7/2/2015
Teva (TEVA) Launches Generic Aggrenox Capsules In The United States 7/1/2015
Information Update - Health Canada Requests Quarantine Of Drugs Linked To Polydrug Laboratories Due To Data Integrity Concerns 6/25/2015
TissueGene, Inc. Announces FDA Acceptance Of Invossa As Proprietary Name For TissueGene-C 6/24/2015
Information Update - Health Canada Requests Quarantine Of Drugs Linked To Zhejiang Hisun Pharma Due To Data Integrity Concerns 6/16/2015
Pfizer Consumer Healthcare (PFE) Breaks Ground On $95 Million China Facility 6/15/2015
Mylan (MYL) Launches First Bioequivalent Alternative To Combination Asthma Therapy Seretide Evohaler (Salmeterol Xinafoate/Fluticasone Propionate) Under the Brand Name Sirdupla In The UK 6/8/2015
Mylan (MYL) Launches Generic Version Of Seasonique Tablets 6/3/2015
Boehringer Ingelheim Release: National Institute for Clinical Excellence (NICE) Recommends VARGATEF (Nintedanib*) In Combination With Docetaxel As An Option For Patients With Non-Small Cell Lung Cancer Of Adenocarcinoma Histology Within Its Licensed Indication 6/3/2015
Cipher Pharma (DND.TO) Strengthens Leadership Team With Key Executive Appointments And Announces Launch Of Vaniqa In Canada 6/2/2015
Teva (TEVA) Enhances ADHD Product Line With Generic INTUNIV In The United States 6/2/2015
Teva (TEVA) Enhances Extensive Women’s Health Portfolio With Launch of Generic Lomedia 24 Fe Tablets 5/29/2015
BioPharm Executive: Here's How The Drug Industry Will Finally Hang Itself 5/28/2015
S-BIO Launching BlotGlyco O-Glycan Sample Preparation Kit In U.S., Japan 5/19/2015
Endo International (ENDP) Announces Updated XIAFLEX Label With Recurrence And Retreatment Data In Patients With Dupuytren's Contracture 5/18/2015
Actavis (ACT) Launches NAMZARIC (memantine hydrochloride Extended-Release And donepezil hydrochloride), A Fixed-Dose Combination Therapy For The Treatment Of Moderate To Severe Alzheimer's Disease 5/18/2015
BMG Pharma S.r.l Announces The Launch Of Its Proprietary Product Ialuxid Gel Under The New Trademark HPO Skin Protect Owned By Centro Internacional De Cosmiatria, S.A.P.I. De C.V. ("FARMAPIEL") In Mexico 5/18/2015
Zambon Launches Xadago (Safinamide) For Patients With Mid- To Late-Stage Parkinson’s Disease In Germany 5/15/2015
Hikma Pharmaceuticals (HIK.L) Launches Caffeine Citrate Injection, Commercialising The First Of The Bedford Products 5/12/2015
Beike Biotechnology Produces High-Dose Adult Stem Cell Packets For Degenerative Conditions 5/6/2015
Mylan (MYL) Launches Generic Seasonale Tablets 5/5/2015
Mylan (MYL) Launches Gilead (GILD)' Sovaldi Tablets In India 5/4/2015
AOP Orphan Pharmaceuticals AG Launches Lojuxta (Lomitapide) For Treatment Of Homozygous Familial Hypercholesterolaemia To The Austrian Market 4/30/2015
Teva (TEVA) Launches Generic Abilify Tablets In The United States 4/29/2015
Teva (TEVA) Continues To Invigorate Injectable Portfolio With The Launch Of Argatroban Injection In The United States 4/28/2015
Actavis (ACT) Launches AVYCAZ (Ceftazidime-Avibactam) Anti-Infective In U.S. 4/23/2015
Perrigo (PRGO) Announces The Launch Of A Generic Version Of Kenalog Nasal Spray 4/17/2015
FDA Panel Wants Heart Risk Warnings for AstraZeneca PLC (AZN), Takeda (TKPYY) Diabetes Drugs 4/16/2015
Pharma Giant GlaxoSmithKline (GSK) to Battle Rowex Over Purple Design of a New Inhaler 4/15/2015
Actavis (ACT) And Medicines360 Announce U.S. Availability Of LILETTA (levonorgestrel-releasing intrauterine system) 52 Mg To Prevent Pregnancy For Up To Three Years 4/14/2015
Sanofi (SAN.PA) Korea Launches Anlit Probiotic Supplement For Kids 4/14/2015
Sanofi (SAN.PA) Stuck Between a Rock and a Hard Place With Lantus Heir Toujeo 4/13/2015
Actavis (ACT) And Medicines360 Announce U.S. Availability Of LILETTA (levonorgestrel-Releasing Intrauterine System) 52 Mg To Prevent Pregnancy For Up To Three Years 4/13/2015
European Medicines Agency's PRAC Recommends Updating Advice On Use Of High Dose Ibuprofen 4/13/2015
Alexion (ALXN) Receives Approval For Important Updates To The European Label For Soliris (Eculizumab) 4/10/2015
Why the Flu Vaccine Barely Worked This Year 4/8/2015
Perrigo (PRGO) Announces FDA Approval And Upcoming Launch Of The AB Therapeutic Equivalent To Exalgo 4/8/2015
Mylan (MYL) Launches First Generic Version Of Generess Fe 4/7/2015
Analyst: A Complete List of All Major Biosimilars Could Be the A to Z Guide 4/6/2015
Novartis AG (NVS) Accused of "Bullying" Doctors to Drop Trial of Cheaper Drugs 4/6/2015
Pfizer (PFE) Halts China Vaccine Business After Import License is Killed; 200 Employees Impacted 4/3/2015
Merck & Co. (MRK)'s HPV Vaccine, GARDASIL9, Now Available In Canada 4/1/2015
Mylan (MYL) Launches Generic Exforge Tablets 3/31/2015
PHEBURANE Now Available For Distribution In Canada Through Medunik Canada 3/30/2015
Hospira's INFLECTRA (Infliximab) Now Available In Canada 3/30/2015
Stempeutics Receives Advanced Therapy Medicinal Product (ATMP) Classification From European Medicines Agency For Its Novel Stem Cell Drug 'Stempeucel' 3/23/2015
Neovasc Inc. (NVC) Launches Reducer In Select European Countries 3/20/2015
Hatchtech Pty Ltd To Explore Strategic Alternatives For Commercialization Of Xeglyze Lotion In The U.S. 3/18/2015
Actavis (ACT) Receives FDA Approval For VIIBRYD (vilazodone HCl) 20mg Once Daily As A Therapeutic Dose 3/17/2015
Duchesnay inc. Release: Expansion Overseas – Diclectin For Nausea And Vomiting Of Pregnancy (NVP) Now Available In Israel 3/17/2015
Endo Pharmaceuticals (ENDP) Announces The Launch Of NATESTO (Testosterone Nasal Gel), The First And Only Nasal Gel For Testosterone Replacement Therapy 3/16/2015
Yisheng Biopharma Co., Ltd. Release: A New Therapeutic Vaccine Successfully Developed Against Rabies 3/16/2015
Advisory - Jamp Pharma Corp Recalls Jamp-Methotrexate (USP 50mg/2mL) Due To Particulate Matter 3/16/2015
Genovis Is Launching A New Enzyme Product 3/12/2015
Mylan Inc. (MYL) Launches First And Only Available Intermediate Dosage Strengths Of Fentanyl Transdermal System 37.5, 62.5 And 87.5 Mcg/Hr 3/11/2015
Mylan Inc. (MYL) Launches Generic Antabuse Tablets 3/11/2015
Take Charge And Become One Of The Alpha Elite With The Launch Of Hantian Labs' Stimulant Free Testosterone And Performance Booster 3/11/2015
Mylan Inc. (MYL) Launches Generic Subutex Sublingual Tablets 3/11/2015
Vectura Group plc (VEC.L) Release: AirFluSal Forspiro Launched In Portugal And Ireland 3/11/2015
Milan, Italy: BMG Pharma S.r.l Announces The Launch Of Its Proprietary Product Ialuxid Gel In The People's Republic Of China By Luqa Pharmaceuticals 3/10/2015
TWi Pharmaceuticals, Inc. Receives Rare Disease Drug Designation For Its Drug Candidate AC-203 In Taiwan 3/10/2015
Actavis (ACT) Launches Generic Version Of Temovate (Clobetasol Cream 0.05%) 3/9/2015
Ipsen (IPN.PA) Announces Third Resupply Of Increlex (Mecasermin [rDNA Origin] Injection) In The U.S. In 2015 3/2/2015
Celltrion, Inc. (068270.KQ) Launches World’s First Biosimilar Monoclonal Antibody Remsima In 12 New European Markets 2/25/2015
TWi Pharmaceuticals, Inc. Announces That It Will Sell Its Products In The U.S. Market, Originally Planned To Be Sold By Teva, Through Its Wholly-Owned Subsidiary, TWi Pharmaceuticals USA 2/24/2015
Celgene International Sárl (CELG) Release: ABRAXANE Now Reimbursed In Italy As A First-Line Treatment Of Adult Patients With Metastatic Pancreatic Cancer 2/24/2015
Ferring Pharmaceuticals Announces European Launch Of CORTIMENT MMX (Budesonide) For Ulcerative Colitis, And New Data Re-Confirms Safety And Efficacy 2/20/2015
Aptalis Pharmaceutical Technologies (FRX) Release: Allegra Dry Syrup 5% Launches In Japan 2/20/2015
Teva Pharmaceutical Industries (TEVA) Bolsters Injectable Portfolio With Launch Of Generic Lovenox And Generic Zyvox In The United States 2/17/2015
Hospira Launches First Biosimilar Monoclonal Antibody (mAb) Inflectra (Infliximab) In Major European Markets 2/16/2015
Teijin Limited Release: Small-sized MUCOSOLVAN L Expectorant Tablet 45 Mg Approved In Japan 2/16/2015
Gilead (GILD) Agrees to a Discounted Price of $46,000 for Sovaldi in Europe 2/13/2015
Ex-Smokers Jittery About GlaxoSmithKline (GSK)'s Nicorette Lozenge Shortage 2/11/2015
BMG Pharma S.r.l Obtained A New Indication On Molluscum Contagiosium For CE Marked Proprietary Product Ialuxid Gel 2/9/2015
Daiichi Sankyo (4568.t) Release: SAVAYSA (edoxaban) Now Available In U.S. Pharmacies 2/9/2015
Tianjin Medical University Cancer Hospital Release: Nanocarrier Drugs for Pancreatic Cancer Now Being Produced In China 2/6/2015
Novartis Pharmaceuticals Canada Inc. Release: Now Available In Quebec, Ultibro® Breezhaler®, A Once-Daily Dual Bronchodilator For Chronic Obstructive Pulmonary Disease (COPD) 2/3/2015
Sanofi (SAN.PA) And MannKind Corporation (MNKD) Announce Afrezza®, The Only Inhaled Insulin, Now Available In The U.S. 2/3/2015
Novartis AG (NVS) Sees Price War With Amgen (AMGN), Eli Lilly (LLY) for Blockbuster Psoriasis Market 1/29/2015
Asia's Biggest Vaccine Maker a Huge Threat to Drugmakers Like Merck & Co. (MRK) 1/28/2015
BioSpace (DHX) Poll Finds Whopping 92% of Respondents Believe Discounts Were Offered in Pricing War 1/27/2015
Disneyland Measles Outbreak Casts Shadow on Anti-Vaccination Movement 1/21/2015
International Charity Slams GlaxoSmithKline (GSK), Pfizer (PFE) for High Vaccine Prices 1/20/2015
Eli Lilly (LLY) Claims Innocence as FDA Bans Mystery Cialis-Viagra Concoction Discovered at Plant 1/14/2015
Breaking: J.P. Morgan: Sanofi (SAN.PA) Says Afrezza Will Be Available in 2015, Snubs MannKind Corporation (MNKD) CEO Retirement News 1/13/2015
Hikma Pharmaceuticals (HIK.L) To Launch Colchicine 0.6mg Capsules 1/12/2015
HUYA Bioscience International Announces Regulatory Approval Of Chidamide, The First Selective HDAC Inhibitor In China 1/12/2015
U.K. Cancer Drugs Fund Delists Big Pharmas' Meds; Novartis AG (NVS) Slams Process 1/12/2015
Teva Pharmaceutical Industries Limited (TEVA) Launches Generic Diovan® In The United States 1/7/2015
Novo Nordisk A/S (NVO) Plans to Use 500 Sales Reps to Promote New Obesity Drug 12/30/2014
UK Agency's Rejection of Eli Lilly (LLY), GlaxoSmithKline (GSK), PharmaMar S.A.'s Ovarian Cancer Drugs Stand 12/24/2014
Jazz Pharmaceuticals (JAZZ) Receives FDA Approval For Intravenous Administration Of Erwinaze® (Asparaginase Erwinia Chrysanthemi) 12/22/2014
Actavis (ACT) Ordered To Keep Selling Alzheimer's Pill 12/12/2014
Lupin Ltd. (LUPN.BO) Launches Authorized Genericfor Celebrex Capsules 12/11/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of First Generic Celebrex® Capsules In The United States 12/10/2014
Actavis (ACT) Launches Generic Version Of Celebrex 12/10/2014
Zydus Cadila Launches World's First Biosimilar Of AbbVie (ABBV)'s Humira In India 12/9/2014
Daiichi Sankyo, Inc. (4568.t) Launches New Formulation Of LIXIANA 60 mg Tablets (edoxaban) In Japan 12/8/2014
Otsuka Pharmaceutical Co., Ltd. Release: U.S. FDA Approves The Labeling Update Of Abilify Maintena® (Aripiprazole) For Extended-Release Injectable Suspension To Describe New Clinical Data For The Treatment Of Acutely Relapsed Adults With Schizophrenia 12/8/2014
Basilea Pharmaceutica (BSLN.SW) Announces Launch Of Antibiotic Zevtera(R) (Ceftobiprole Medocaril) In Germany 12/5/2014
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved In Germany 12/4/2014
EPIRUS Biopharmaceuticals Remicade® Biosimilar, Infimab™, Launches In India 12/2/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Exforge HCT® Tablets In The United States 12/1/2014
SkyePharma Inc. (SKYE)’s Partner Kyorin Pharmaceutical Co., Ltd. Launches 120-Puff Version Of Flutiform In Japan 12/1/2014
flutiform® Launched In Spain; Abriff® Launched In Italy SkyePharma Inc. (SKYE) To Receive €2 Million Milestone From Mundipharma International Limited 12/1/2014
Actavis (ACT) Launches Generic Version Of Intuniv 12/1/2014
IntelGenx Corp. Announces Update To Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/26/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Docetaxel Injection USP 11/24/2014
Perrigo Company (PRGO) Announces The Launch Of A Generic Version Of Astellas' Protopic Ointment 0.1% And 0.03% 11/24/2014
Sanofi (SAN.PA) Aims To Launch 18 New Drugs By 2020 11/21/2014
European Medicines Agency Recommends Availability Of Laboratoire HRA Pharma's Ellaone Emergency Contraceptive Without Prescription 11/21/2014
France Strikes Deal For Gilead Sciences, Inc. (GILD)'s Hep C Drug Sovaldi 11/21/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Over-The-Counter Fexofenadine Hydrochloride 60 Mg And Pseudoephedrine Hydrochloride 120 Mg Extended-Release Tablets 11/20/2014
Teva Canada Announces the Launch of (Pr)Teva-Celecoxib, a generic of (Pr)Celebrex/ 11/18/2014
AstraZeneca PLC (AZN) Shows Off Strong Drug Pipeline As Pfizer (PFE) Deadline Looms 11/18/2014
Mallinckrodt Pharmaceuticals (MNK) Responds To FDA’s Expected Reclassification Of Methylphenidate ER 11/14/2014
Mallinckrodt Pharmaceuticals (MNK)'s Generic ADHD Drug Does Not Measure Up To Johnson & Johnson (JNJ)'s Concerta: FDA 11/14/2014
Novartis AG (NVS) To Deliver Three Million Malaria Treatments For Kids In Zambia 11/13/2014
Major Medical Centers Ask Congress To Probe Genentech (RHHBY)'s Distribution Changes 11/13/2014
Five Percent Of Medicines In Malaysia Are Counterfeit: Pfizer (PFE) 11/11/2014
Oculus Innovative Sciences, Inc. (OCLS) Commercializes Microcyn®-Based Solution And Hydrogel For Treatment Of Mild-To-Moderate Acne In Europe 11/11/2014
Babies Die While Officials Haggle With Novartis AG (NVS) Over Cost Of Bexsero Vaccine 11/11/2014
When Will Biosimilars Impact The U.S. Market? 10/30/2014
European Medicines Agency Completes Review Of Polymyxin-Based Medicines 10/24/2014
BioSpace’s Favorite FDA Tricks Or Treats 10/24/2014
Takeda Pharmaceuticals And Orexigen Therapeutics, Inc. (OREX) Announce Availability Of CONTRAVE® (naltrexone HCI And bupropion HCI) Extended-Release Tablets For Chronic Weight Management In Obese Adults 10/20/2014
Admedus Cardiocel® To Be Launched In Canada 10/20/2014
Government Of Canada Ships NewLink Genetics' Ebola Vaccine To The WHO 10/20/2014
Sihuan Pharmaceutical Sends Ebola Drug JK-05 To Africa, Eyes Clinical Trials 10/16/2014
Health Canada Release: Safety Information On The Risk Of Blood Clots With Immunoglobulin Products 10/13/2014
Orexo AB (ORXOF) Submits Application To FDA For Expanded Label Of ZUBSOLV® 10/13/2014
Gilead Sciences, Inc. (GILD)'s Solvadi May Be Barred From UK's Service Plan 10/9/2014
National Institute for Clinical Excellence (NICE) Rejects Another Roche (RHHBY) Leukemia Drug Citing Data Uncertainties 10/6/2014
FUJIFILM's Toyama Chemical Avigan Tablet 200mg Administered To Patients Infected With Ebola Virus 10/6/2014
Janssen-Cilag International NV (JNJ) Release: CHMP Announces Positive Opinion For REZOLSTA™, A New Once-Daily, Fixed-Dose HIV Therapy Combining Darunavir And Cobicistat 9/29/2014
FUJIFILM's Toyama Chemical Avigan Tablet 200mg Administered To A French Woman Infected With Ebola Virus 9/26/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Levalbuterol Inhalation Solution, USP 9/24/2014
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved For The European Union 9/22/2014
Janssen Pharmaceutical Inc. Release: Prezcobix™ Now Available For Canadians Living With HIV 9/17/2014
Novartis AG (NVS), Roche (RHHBY) Cry Foul On New Swiss Pricing System 9/16/2014
Roche (RHHBY) Battles Counterfeit Rituxin Vials In Germany 9/15/2014
EMD Serono Canada Inc. Announces Launch Of The Eeva® Test In Canada 9/11/2014
Endo International plc (ENDP) Announces Launch Of Authorized Generic Of FORTESTA® Gel 9/8/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Baraclude® Tablets, 0.5mg And 1mg, In The United States 9/4/2014
Cipla Ltd. Takes A Bite Out Of GlaxoSmithKline (GSK)'s Profits As Copy Of Top Asthma Drug Lauches In Germany, Sweden 9/2/2014
BioTie Therapies Corp.: Selincro Enters The Market In Germany 8/29/2014
Fresenius Kabi AG Introduces Acetylcysteine Solution 10% In 4 Ml, 10 Ml And 30 Ml Vials 8/18/2014
Sanofi (France) (SAN.PA), PATH Roll Out First Large-Scale Batches Of Antimalarial Drug 8/12/2014
Another Controversial High Price Med: National Institute for Clinical Excellence (NICE) Rejects Roche (RHHBY)'s New $152,850 Breast Cancer Drug 8/11/2014
Fresenius Kabi AG Release: Diprivan® (Propofol) Injectable Emulsion, USP Now Available In 10 Ml Vials 8/11/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces The Launch Of ADASUVE® (Inhalation Powder, loxapine) In Guatemala 8/8/2014
bioCSL Inc. Launches AFLURIA® Shipping Campaign For 2014-2015 Seasonal Influenza 8/5/2014
Troubled GlaxoSmithKline (GSK) Gets A Lift As Express Scripts Inc. Reinstates Lung Drug Advair 8/5/2014
Certara Corporation Launches D360 In Japan To Improve Drug Discovery And Development Productivity 8/4/2014
INNOPHARMA Announces Launch Of Olanzapine For Injection, 10mg/Vial In Canada 7/30/2014
AstraZeneca PLC (AZN) Fights With Pediatrician Group Over Preemie Drug Guidelines 7/29/2014
Perrigo Company (PRGO) Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 7/28/2014
FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States 7/24/2014
Iroko Pharmaceuticals Continues To Expand Commercialization Of ZORVOLEX Ex-US 7/22/2014
BioTie Therapies Corp.: Selincro Enters The Market In Spain 7/22/2014
Shire Release: Firazyr®: First Subcutaneous Treatment For Acute Attacks Of Rare And Serious Swelling Disorder Now Available In Canada 7/21/2014
BioAlliance Pharma Announces The Launch Of Sitavig® In The United States By Its Partner Innocutis 7/21/2014
Basilea Pharmaceutica (BSLN.SW) To Launch Zevtera®/Mabelio®) (ceftobiprole medocaril) In Europe Through A Commercial Services Provider 7/21/2014
Bial And moksha8 Announce Exclusive License For The Commercialization Of Eslicarbazepine Acetate (Zebinix® / Exalief®) In Brazil And Mexico 7/15/2014
EU Nations Join Forces Against Gilead Sciences, Inc. (GILD)'s "Exorbitant" Hepatitis C Drug 7/14/2014
NicOx SA (COX.PA) Focuses U S. Operations On National Launches Of Sjo™ And Retnagene™ And Restructures RPS® Licensing Agreement 7/10/2014